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million people older than 18 years 
of age and 8 million people be-
tween the ages of 12 and 18. 
More than 4% of them had anti-
bodies to hepatitis C, of whom 
nearly 75% had active viremia; 
21% screened posi-
tive for hyperten-
sion; and about 5% 
screened positive for diabetes. 
Counseling is under way for the 
40% of the screened population 
that is considered obese by WHO 
standards.
Virtually all people identified 
as having active virus replication 
have been effectively treated. 
Egypt may soon be the first 
country to eliminate hepatitis C. 
The success of this program sug-
gests that other countries could 
effectively pursue other chronic 
and infectious diseases by using 
similar strategies. It may be hard 
work to get there, but Egypt has 
proven that universal screening 
for a range of diseases is not im-
possible. Drug-pricing challenges 
can be overcome. Treatments can 
be made available for all.
Disclosure forms provided by the author 
are available at NEJM.org.
From ACCESS Health International and the 
Haseltine Foundation for Science and the 
Arts, New York. 
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Misdiagnosis, Mistreatment, and Harm — When Medical Care 
Ignores Social Forces
Seth M. Holmes, Ph.D., M.D., Helena Hansen, M.D., Ph.D., Angela Jenks, Ph.D., Scott D. Stonington, M.D., Ph.D., 
Michelle Morse, M.D., M.P.H., Jeremy A. Greene, M.D., Ph.D., Keith A. Wailoo, Ph.D., 
Michael G. Marmot, M.B., B.S., Ph.D., and Paul E. Farmer, M.D., Ph.D. 
In a 2019 op-ed in the Wall Street Journal entitled “Take Two Aspi-
rin and Call Me by My Pronouns,” 
former University of Pennsylvania 
Dean of Medical Education Stan-
ley Goldfarb echoed a dismissal 
that some physicians have been 
voicing for decades. Why should 
medical training focus on social 
factors, Goldfarb asked, when 
medicine’s purpose is to cure in-
dividual patients? His essay as-
sumed that one can effectively 
cure patients while ignoring the 
world in which they live. Unfor-
tunately, that is an empirically 
untenable position.
Between November 2018 and 
January 2020, the New England 
Journal of Medicine published month-
ly Case Studies in Social Medi-
cine, exploring concepts from the 
social sciences that can help us 
respond to the influence of social 
factors in the practice of medicine 
(see table). These cases were de-
veloped to demonstrate how clini-
cians can help manage social 
forces and their health effects. In 
addition, we found that the arti-
cles help demonstrate that with-
out the skills to identify and re-
spond to those forces, physicians 
are at risk of misdiagnosing, 
mistreating, and ultimately caus-
ing harm. When physicians use 
only biologic or individual behav-
ioral interventions to treat dis-
eases that stem from or are exac-
erbated by social factors, we risk 
harming the patients we seek to 
serve.
Social, political, and economic 
structures — those highlighted 
by Goldfarb as well as structural 
racism, settler colonialism, other 
structures of marginalization, and 
the inequalities each of these 
produces — are injuring and 
killing people. To stop these pro-
cesses, we need a range of com-
munity- and team-based inter-
ventions, many of which occur 
beyond clinical practice — such 
as urban and regional planning 
to ensure the availability of safe 
housing and healthy food, and 
policy and systems changes to 
guarantee fair access to gainful 
employment and protection from 
environmental degradation. As 
clinicians, we endeavor to treat 
our patients’ diseases and inju-
ries. But when we dismiss social 
factors as peripheral, we not only 
miss opportunities to improve 
outcomes, we may in fact fail at 
medicine’s core responsibilities to 
diagnose and treat illness and 
to do no harm.
Physicians risk misdiagnosis 
when we fail to take social struc-
tures into account or misattribute 
their effects to biologic mecha-
nisms or individual behaviors. A 
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well-recognized example of large-
scale misdiagnosis involves the 
multiple, intertwined epidemics 
of chronic disease that are relat-
ed to housing and food insecu-
rity in low-income neighborhoods. 
These diseases — including dia-
betes, heart disease, obesity, 
asthma, mood and anxiety disor-
ders, and substance use disorder 
— cluster together sociogeograph-
ically into what have been termed 
“syndemics.”1 “Dietary counsel-
ing” may be farcical when pa-
tients with diabetes cannot acquire 
lean proteins and vegetables. And 
escalating doses of inhaled asth-
ma medication may be futile for 
children living in high-allergen 
or environmentally contaminated 
housing. Syndemics are related 
to certain neighborhoods’ unsta-
ble housing and dearth of healthy 
food, which reflect a history of 
institutional racism — including 
redlining — and stark socioeco-
nomic inequalities produced by 
capitalism.
When chronic conditions are 
viewed as solely biologic or be-
havioral malfunction, the diag-
nosis misses the true causes, and 
often, misdiagnosis leads to in-
effective treatments. But clini-
cians and health care adminis-
trators can work to appropriately 
diagnose and treat the institu-
tional and social drivers of syn-
demic disease. For example, clini-
cians and public health advocates 
have persuaded the states of Ore-
gon, New York, and Massachusetts 
to devote Medicaid spending to af-
fordable, safe housing and have 
reduced food insecurity in U.S. 
cities through clinic- and commu-
nity-based food-access programs.
Without acknowledging or re-
sponding to social structures, 
clinicians may perpetuate mis-
treatment, providing ineffective 
responses to our patients’ medi-
cal problems. There are aspects 
of peoples’ lives outside medical 
care that determine whether they 
get sick and how well or poorly 
our treatments “fit” them. These 
social forces are also active with-
in medicine, determining whom 
we treat, how we treat them, 
where we put hospitals and clin-
ics, which specialties and care-
givers we prioritize and fund, and 
what goals we set for treatment.
One example involves clini-
cians’ necessary interactions with 
financial institutions such as in-
surance companies, which affect 
some patients more negatively 
than others, depending on their 
socioeconomic, immigration, ra-
cial, colonized, or other margin-
alized status. In one documented 
case, a patient with gastric can-
cer underwent biopsy and imag-
ing for staging and chemother-
apy planning and then had to 
wait 3 months for insurance ap-
proval. By that time, lab tests re-
vealed worsened liver function 
and increased levels of tumor 
markers and repeat imaging 
showed new metastases necessi-
tating altered chemotherapy and 
radiation regimens. This change 
in prescription required another 
3-month wait for approval, and 
the patient died without receiv-
ing a single medication.2
Such financially motivated re-
strictions are just one instance of 
Case Studies in Social Medicine Series.*
Case Social Concept
Treating the fundamental drivers of  
patient health
Carrasco et al . Misrecognition and critical consciousness
Seymour et al . Structural differential
Knight et al . Reproductive (in)justice
Karandinos et al . Structural violence of hyperincarceration
Pallok et al . Structural racism
Navigating structural and bureaucratic 
barriers to care
Stonington et al . Structural iatrogenesis
Berlin et al . The right and left hands of the state
Braslow et al . Medicalization and demedicalization
Madaras et al . Social distance and mobility
Kalofonos Biological citizenship
Critically applying medical knowledge 
and categories
Friedner et al . Disability justice and multiple normals
Stroumsa et al . The power and limits of classification
Aronowitz et al . Contingent knowledge and looping effects
Béhague et al . Dialogic praxis
Chowdhury et al . Democratizing evidence production
*  The series was introduced in a Medicine and Society article by Stonington et al . 
(Case Studies in Social Medicine — Attending to Structural Forces in Clinical Practice. 
N Engl J Med 2018;379:1958-61).
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social, political, and economic 
structures leading to inappropri-
ate treatments and poor outcomes. 
Training in social medicine and 
structural competency can pre-
pare clinicians to identify such 
constraints and work toward so-
lutions for their patients and 
practices. Many clinicians, for 
example, play important roles in 
growing social movements for 
health care access for all.
Beyond misdiagnosis and mis-
treatment, medical care that ig-
nores social structures may cause 
patients real and measurable 
harm, in a manner similar to the 
iatrogenic harms of medical mis-
takes. One example is the role of 
physicians in the ongoing opioid 
epidemic. The aggressive market-
ing of opioids by the pharmaceu-
tical industry and false claims 
used to gain Food and Drug Ad-
ministration approval have been 
widely publicized. And physicians 
who have failed to change pat-
terns of inappropriate pain man-
agement are increasingly the tar-
gets of lawsuits and public anger. 
More broadly, population health 
researchers point to social condi-
tions such as postindustrial un-
employment and disintegration of 
social networks and community 
institutions as the root causes of 
epidemic pain and reliance on 
narcotics, recognizing opioid over-
doses as “deaths of despair.”3 Phy-
sicians are front-line witnesses to 
community-level despair, but we 
are generally equipped only to 
prescribe opioids in response, 
rather than to investigate and 
collaboratively address the social 
problems leading our patients to 
seek these prescriptions. A clini-
cal workforce educated in social 
medicine principles would be 
more skilled in questioning the 
corporate influences that propa-
gated inappropriate opioid pre-
scribing, while identifying and 
intervening in the social drivers 
of demand for opioids.
The centrality of social factors 
in clinical care has long been rec-
ognized by physicians — from 
Rudolf Virchow, the 19th-century 
“founder of modern pathology,” 
who traced typhoid epidemics to 
living conditions in central Eu-
rope, to leaders of the Association 
of American Medical Colleges 
and the Institute of Medicine 
(now the National Academy of 
Medicine), who have issued posi-
tion statements on this topic. 
The National Research Council 
recently reported that the United 
States spends more money on 
health care than any other coun-
try yet has the poorest health 
outcomes among peer nations, 
largely owing to social structural 
factors.
Inequitable social structures 
not only harm patients; they also 
subvert our attempts to provide 
effective care. ln fact, among the 
growing number of physicians 
who report experiencing burnout 
or even leaving clinical practice, 
many cite systemic barriers to ef-
fective care as an important fac-
tor. The Robert Wood Johnson 
Foundation has reported that the 
vast majority of physicians nation-
wide identify social factors as 
critical to clinical outcomes — 
but indicate a need for tools for 
addressing the social drivers of 
health and illness. There is enor-
mous progress to be made, given 
that the majority of U.S. medical 
schools and residency programs 
lack faculty with expertise in so-
cial medicine, curricula for teach-
ing it, and training sites where it 
is practiced.
Clinicians are uniquely posi-
tioned to respond to the social, 
political, and economic structures 
affecting our patients’ health. If 
we fail to do so, we risk misdiag-
nosis, mistreatment, and iatro-
genic harm. We are convinced 
that undergraduate, graduate, and 
continuing medical education in 
structural competency and other 
social medicine frameworks4 can 
be used to train clinicians who 
will thrive while effectively con-
fronting the health problems 
caused by inequitable social struc-
tures.5 A grasp of such frame-
works would lead physicians to 
interact differently with patients, 
communities, interprofessional 
teams, health care systems, and 
the societies and world in which 
we live. Then millions of patients 
could receive medical care that is 
effective and does no harm.
Disclosure forms provided by the authors 
are available at NEJM.org.
From the University of California Berkeley, 
Berkeley, and the University of California 
San Francisco, San Francisco (S.M.H.); 
New York University, New York (H.H.); the 
University of California Irvine, Irvine (A.J.); 
the University of Michigan, Ann Arbor 
(S.D.S.); Brigham and Women’s Hospital 
and Harvard Medical School — both in 
Boston (M.M., P.E.F.); Johns Hopkins Uni-
versity, Baltimore (J.A.G.); Princeton Uni-
versity, Princeton, NJ (K.A.W.); and Univer-
sity College London, London (M.G.M.). 
When chronic conditions are viewed as solely 
biologic or behavioral malfunction, the diagnosis  
misses the true causes, and often, misdiagnosis  
leads to ineffective treatments.
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Opioid Prescribing in the Midst of Crisis
Opioid Prescribing in the Midst of Crisis — Myths and Realities
Michael L. Barnett, M.D. 
The once-simple act of writing an opioid prescription has 
become fraught. Physicians must 
check prescription monitoring 
databases to review patients’ his-
tories, make sure their prescrip-
tion complies with state limits 
on dose or number of days’ sup-
ply, and consider any practice-
quality measures that might be 
affected. Beyond regulatory re-
quirements, physicians must con-
tend with growing stigma in the 
medical community against using 
opioids for pain management. 
Not surprisingly, there can be a 
palpable chill when a discussion 
about managing pain drifts to-
ward opioids. Should I really start 
them? What if the patient de-
mands more? What if I end up 
prescribing them long-term? Years 
of relaxed attitudes toward opi-
oids have given way to an atmos-
phere of apprehension.
In many ways, this caution is a 
positive development since 2011, 
when prescribing opioids for pain 
seemed as routine as giving anti-
biotics for a urinary tract infec-
tion. According to the data sci-
ence firm IQVIA, the volume of 
opioids prescribed per year quad-
rupled between 1991 and 2011. 
Many patients took only a frac-
tion of the supply they received, 
and substantial quantities of opi-
oids were diverted for nonmedi-
cal use. Opioid-related overdose 
deaths soon began increasing ex-
ponentially, a trend that evolved 
into a crisis fueled by intravenous 
heroin and fentanyl use. The con-
sequences of overprescribing con-
tinue to reverberate.
The medical community has 
since reversed course. As of 2018, 
the total volume of opioid pre-
scriptions nationally had fallen 
by more than 40% from “peak 
opioid” around 2011. Undoubted-
ly, much of this decrease has 
come from shedding avoidable 
use, but stories are emerging of 
prescribers abandoning opioids 
indiscriminately, particularly for 
the millions of U.S. patients with 
chronic pain. Like many other 
public debates, the opioid-prescrib-
ing debate seems hopelessly po-
larized: either opioids are indus-
trially sponsored weapons of mass 
addiction or they’re a misunder-
stood last hope for alleviating 
suffering. The optimal use of these 
medications lies between these 
two poles — but where, exactly? 
There’s no definitive answer, but 
there are persistent myths and 
misunderstandings that contrib-
ute to overprescribing or under-
prescribing (see table).
Perhaps the most durable myth 
leading to overprescribing is that 
opioids are uniquely effective for 
pain control — they are special, 
powerful analgesics that are some-
times held back until others don’t 
work, just as the most powerful 
antibiotics are reserved for espe-
cially severe, resistant infections. 
This belief was codified in the 
World Health Organization’s 
analgesic “ladder” for cancer-pain 
treatment, which placed nonste-
roidal antiinf lammatory drugs 
(NSAIDs) on the bottom rung for 
mild pain and opioids on higher 
rungs for persistent moderate-to-
severe pain.
I encounter this myth frequent-
ly in caring for patients, who 
may believe they’re being denied 
the “real thing” if they are of-
fered only NSAIDs for severe 
pain. In reality, although opioids 
do treat pain, there is little evi-
dence that they have a clear ad-
vantage over NSAIDs,1 muscle re-
laxants,2 or other alternative pain 
treatments such as tricyclic anti-
depressants3 for many conditions. 
A less generous interpretation of 
the evidence is that opioids are 
inferior to NSAIDs because of 
their less favorable side-effect 
profile for either short- or long-
term treatment. The clinical im-
plication is that there is no rea-
son to give opioids a special, 
privileged status in pain control. 
They are simply another thera-
peutic option, best tried after 
NSAIDs and other alternatives if 
